Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 15 mcgHA/Strain/0.5mL) for the Use in the Season 2013/2014 in Adult and Elderly Subjects
Latest Information Update: 06 Apr 2021
Price :
$35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Fluart Innovative Vaccines
- 19 Oct 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2013 New trial record